Effect of vibration frequency on finger blood flow
Abstract
A total of 18 healthy subjects (9 men and 9 women) 20-35 years of age were used to study the effect of vibration frequency on finger blood flow. Seven vibration frequencies of 16, 31.5, 63, 125, 250, 500 and 1,000 Hz, at vibrational accelerations of 10 m/s2 (rms: root mean square) or 50 m/s2 (rms), with the exception of 16 Hz, which was measured at only 10 m/s2 (rms), were randomly applied to the palm of the right hand for 1 min at intervals of about 3 min. Finger blood flow was measured simultaneously in both the right and the left middle fingers with a blood flowmeter using a thermal diffusion method and in the left middle finger with a laser Doppler flowmeter. The experiments were performed in an artificial climate chamber set at 23 degrees C air temperature and 50% humidity. Relatively great responses were observed at frequencies of 31.5-63 and 250-500 Hz on the exposed and unexposed sides, respectively, as measured with a blood flowmeter using a thermal diffusion method and at 31.5-63 as well as 500 Hz on the unexposed side with a laser Doppler flowmeter. These results may be related to Meissner's and pacinian corpuscles.
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 18 participants or records.
Read the paper
Related studies
- Preliminary Toxicity Analysis of 3DCRT versus IMRT on the High Dose Arm of the RTOG 0126 Prostate Cancer Trial
- Adaptive Radiotherapy for Head and Neck Cancer: Initial Clinical Outcomes from a Prospective Trial
- American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology
- Motion Management Strategies and Technical Issues Associated with Stereotactic Body Radiotherapy of Thoracic and Upper Abdominal Tumors: A Review from NRG Oncology
- High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial
- Highly efficient training, refinement, and validation of a knowledge-based plan quality control system for radiotherapy clinical trials
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.